Stone House Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31K | Hold |
1,000
| – | – | ﹤0.01% | 318 |
|
|
2025
Q1 | $8.87K | Buy |
+1,000
| New | +$8.87K | ﹤0.01% | 263 |
|
|
2024
Q4 | – | Sell |
-1,000
| Closed | -$27.4K | – | 246 |
|
|
2024
Q3 | $27.4K | Hold |
1,000
| – | – | 0.01% | 158 |
|
|
2024
Q2 | $24.5K | Hold |
1,000
| – | – | 0.01% | 170 |
|
|
2024
Q1 | $21.3K | Hold |
1,000
| – | – | 0.01% | 184 |
|
|
2023
Q4 | $19.1K | Hold |
1,000
| – | – | 0.01% | 124 |
|
|
2023
Q3 | $16K | Hold |
1,000
| – | – | 0.01% | 130 |
|
|
2023
Q2 | $23.2K | Hold |
1,000
| – | – | 0.01% | 108 |
|
|
2023
Q1 | $23.2K | Buy |
+1,000
| New | +$23.2K | 0.01% | 119 |
|
|
2019
Q2 | – | Sell |
-154
| Closed | -$5K | – | 143 |
|
|
2019
Q1 | $5K | Buy |
+154
| New | +$5K | ﹤0.01% | 183 |
|